A monitoring system for cardiac operations with cardiopulmonary bypass comprising: a processor operatively connected to a heart-lung machine; a pump flow detecting device connected to a pump of the heart-lung machine to continuously measure the pump flow value and send it to the processor; a hematocrit reading device inserted inside the arterial or venous line of the heart-lung machine to continuously measure the blood hematocrit value and to send it to the processor; a data input device to allow the operator to manually input data regarding the arterial oxygen saturation and the arterial oxygen tension; computing means integrated in the processor to compute the oxygen delivery value on the basis of the measured pump flow, the measured hematocrit value, the preset value of arterial oxygen saturation, and the preset value of arterial oxygen tension; and a display connected to the processor to display in real-time the computed oxygen delivery value.

Methods and apparatus are provided for non-invasive blood analysis. A blood analysis device (10, 30) comprises a housing (24) for receiving a human or animal body part or a container of blood. The housing (24, 32) comprises at least one wave emitter (18) for emitting an emitted wave to target blood, and at least one wave sensor (26) for sensing a response wave after the emitted wave has interacted with the target blood. The at least one wave sensor is configured to output at least one sense signal allowing a frequency spectrum of the emitted wave to be constructed.

A method for performing free breathing pixel-wise myocardial T1 parameter mapping includes performing a free-breathing scan of a cardiac region at a plurality of varying saturation recovery times to acquire a k-space dataset; generating an image dataset based on the k-space dataset; and performing a respiratory motion correction process on the image dataset. The respiratory motion correction process comprises selecting a target image from the image dataset, co-registering each image in the image dataset to the target image to determine a spatial alignment measurement for each image, and identifying a subset of the image dataset comprising images with the spatial alignment measurement above a predetermined value. Following the respiratory motion correction process, a pixel-wise fitting is performed on the image dataset to estimate T1 relaxation time values for the cardiac region. Then, a pixel-map of the cardiac region is produced depicting the T1 relaxation time values.

A concentration measurement apparatus measures a temporal relative change amount (ΔcHb, ΔO.sub.2Hb) of either or both of total hemoglobin concentration and oxygenated hemoglobin concentration in the head that vary due to repetition of chest compression, and includes a light incidence section making measurement light incident on the head, a light detection section detecting the measurement light propagated through the interior of the head and generating a detection signal in accordance with the intensity of the measurement light, and a CPU determining, based on the detection signal, the relative change amount (ΔcHb, ΔO.sub.2Hb) and performing a filtering process of removing frequency components less than a predetermined frequency from frequency components contained in the relative change amount (ΔcHb, ΔO.sub.2Hb).

A method of non-invasively monitoring hematocrit levels includes monitoring a first emission response to the light provided at the first excitation wavelength, wherein the first emission response is monitored at a first wavelength and monitoring a second emission response to the light provided at the first excitation wavelength, wherein the second emission response is monitored at a second wavelength. A ratiometric value is calculated based on a ratio of the first emission response to the second emission response, wherein the ratiometric value corresponds with hematocrit level of the patient.

To provide a concentration measurement method that makes it possible to accurately, quickly, and non-destructively measure the concentration of a predetermined chemical component to a trace level of concentration by a simple means, that makes it possible to accurately and quickly measure the concentration of a chemical component within an object to be measured to a nano-order trace concentration level in real time, and that has a versatility which makes it possible to adapt said concentration measurement method to a variety of situations and embodiments. A time sharing method is used to irradiate an object to be measured with each of light of a first wavelength and light of a second wavelength having different light absorption rates with respect to the object to be measured, light of each of said wavelengths that arrives optically through the object to be measured as a result of irradiating with the light of each of said wavelengths is received by a shared light reception sensor, a signal relating to light of the first wavelength and a signal relating to light of the second wavelength are output from the light reception sensor in accordance with the received light and a differential signal of said signals is formed, and the concentration of a chemical component in the object to be measured is derived on the basis of the differential signal.

Described is a hemoglobin and hematocrit analyzer, and an analyzing method thereof. The method includes: scanning and taking an image signal of the palpebral conjunctiva of a subject by a scanning unit; receiving the image signal by an analyzing unit connected to the scanning unit; providing a default colorimetric scale by a database connected to the analyzing unit; inputting a clinical test result into the analyzing unit through an input unit connected to the analyzing unit. The image signal is transformed by the analyzing unit to a measured color value. The measured color value is compared with the default colorimetric scale to obtain a test result. The measured color value and the clinical test result are provided as feedback to the database.

Electrochemical test sensors and analysis methods are described that reduce or eliminate the pre-treatment or dilution of blood samples prior to HbA1c analysis. Thus, a blood sample obtained from a blood draw or phlebotomy may be introduced to the electrochemical test sensor for HbA1c analysis. The described test sensors immobilize or deactivate incompatible reagents, enzymes, and antibodies so they do not substantially interfere with each other during the analysis. The test sensors also use heat to catalyze reactions that otherwise would proceed at too slow of a rate to be practical.

A computing system (118) includes a computer readable storage medium (122) with computer executable instructions (124), including a including a biophysical simulator (126) with a segmentor (202) and a boundary condition determiner (206). The computing system further includes a processor (120) configured to execute the biophysical simulator to compute a fractional flow reserve index with cardiac imaging data and at least one of an adapted coronary tree segmentation and an adapted boundary condition.

According to an exemplary embodiment of the present disclosure, apparatus and method can be provided for determining information regarding a tissue or an object at or within the tissue. For example, with at least one first arrangement which is situated inside a particular organ of the body, it is possible to generate at least one electromagnetic radiation in the tissue, wherein the tissue is different from and outside of the particular organ. The particular signals that are responsive to the at least one electromagnetic radiation can be detected (e.g., possibly with at least one second arrangement), at least one characteristic of the tissue and/or information regarding the object at or in the tissue can be determined (e.g., with the second arrangement(s)). Alternatively or in addition, the tissue can be different from and outside of the particular organ, and the first arrangement(s) can be situated inside a particular organ of the body. To that end, the can include (i) the heart, (ii) major vessels attached to the heart, (iii) coronary artery, and/or (iv) blood therein.